PreOPerative Imaging of NeuroEndocrine Tumors
NCT03958188 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 47
Last updated 2019-05-28
Summary
Neuro-endocrine tumours (NET) are the most frequent tumours of the small intestine. In spite of their small size, these tumours have the particularity of forming mesenteric metastasis and ganglionic secondary lesions along the superior mesenteric axis, which is in close proximity to the superior mesenteric artery (SMA).
Surgery is the only curative treatment. The complete resection being a factor for good patient prognosis, risks of subsequent local complications (occlusion, bleeding) must be discussed. The limiting factor for resectability is arterial vascular invasion considering the risk of postoperative small bowel syndrome.
At the moment, the choice of imaging examination and its protocol is not standardized, nor the description of the tumoral mesenteric and ganglionic extension, especially the criteria defining a lymph node as lymphadenopathy. In addition, the complexity of SMA's anatomy and the absence of criteria for arterial invasion defining arterial invasion may lead to a misinterpretation of the preoperative imaging , and thus to an incomplete planning of the surgical procedure.
To correct this absence of radiological standardization, the investigating team has developed a reading grid for Computed Tomography (CT) aimed to facilitate preoperative planning of small bowel NET.
The main objective of the current study is to improve the semiotic description of the mesenteric and ganglionic tumoral extension of small intestine NET using a technically optimized imaging examination and a standardized reading grid in order to plan the best surgical procedure which would allow maintaining a minimal length of small intestine needed to yield a satisfying quality of life and nutritional status.
The secondary objective of this study is to evaluate the reproducibility of the standardized scanner's reading grid.
Conditions
- Neuro-endocrine Tumors
- Small Intestine Cancer
Interventions
- OTHER
-
Standardized computerized tomography (CT) reading grid for preoperative planning
Using the standardized reading grid, the following data will be collected: * Small Intestine: tumor, parietal thickening, occlusive syndrome, proximity of the tumor with the ileocecal valve. * Mesenteric mass: presence, size, shape, contours, calcifications, enhancement, superior mesenteric arterial invasion and number of non-invaded arterial arteries. * Mesentery: moniliform venous dilatations, combed appearance. * Duodenal invasion. * Lymphadenopathies (Mesenteric, Right mesocolic and Retropancreatic): presence, size, shape, enhancement The anonymized CT exam will be reviewed by an expert radiologist and a radiology resident from imaging department of the Hospital.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Romain L'Huillier · Hospices Civils de Lyon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2019-06-30
- Completion
- 2019-12-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
NCT01967537 ·Status: COMPLETED ·Phase: PHASE2
-
DOTATOC PET/CT for Imaging NET Patients
NCT03583528 ·Status: ACTIVE_NOT_RECRUITING
-
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
NCT06155318 ·Status: RECRUITING
-
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
NCT05537675 ·Status: COMPLETED
-
Study to Measure the Safety of 68Ga-DOTA-TATE PET/CT in the Diagnosis of Tumors Expressing Somatostatin Receptors
NCT02810600 ·Status: COMPLETED
-
68Ga-DOTA-TATE PET/CT Imaging in NETs
NCT04847505 ·Status: RECRUITING ·Phase: PHASE3
-
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
NCT05673031 ·Status: RECRUITING
-
Community-based Neuroendocrine Tumor (NET) Research Study
NCT02730104 ·Status: COMPLETED
-
PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105
NCT03278275 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
NCT06159920 ·Status: RECRUITING
-
PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation
NCT02134639 ·Status: COMPLETED
-
68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
NCT02174679 ·Status: NO_LONGER_AVAILABLE
-
Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors
NCT07178587 ·Status: RECRUITING ·Phase: NA
-
Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations
NCT02858167 ·Status: COMPLETED ·Phase: NA
-
Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors
NCT04804371 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry
NCT06460467 ·Status: COMPLETED
-
Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan
NCT03136328 ·Status: COMPLETED ·Phase: PHASE3
-
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
NCT05358340 ·Status: UNKNOWN ·Phase: NA
-
18F-AmBF3-TATE PET/CT for Imaging NET Patients
NCT04207762 ·Status: COMPLETED
-
Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions
NCT05934994 ·Status: RECRUITING ·Phase: NA
-
Prospective Study on Oncologic Cerebral Imagery Contribution by 18F-FDOPA Position Emission Tomography (PET)
NCT02022800 ·Status: COMPLETED ·Phase: NA
-
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
NCT02359500 ·Status: TERMINATED ·Phase: PHASE1
-
PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
NCT03271281 ·Status: COMPLETED ·Phase: PHASE2
-
61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
NCT06455358 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Interest of Whole-body MRI Correlated to Spreading Sequences for Staging Neuroendocrine Tumors
NCT02786303 ·Status: UNKNOWN ·Phase: NA